Skip to main content
Top
Published in: BMC Ophthalmology 1/2016

Open Access 01-12-2016 | Research article

A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially

Authors: Nan Jiang, Guiqiu Zhao, Shanshan Yang, Jing Lin, Liting Hu, Chengye Che, Qian Wang, Qiang Xu

Published in: BMC Ophthalmology | Issue 1/2016

Login to get access

Abstract

Background

Rhino-orbito-cerebral mucormycosis(ROCM) is an invasive fungal infection that usually occurs in immunocompromised patients and sometimes presents as orbital apex syndrome(OAS) initially. It is rapidly fatal without an early diagnosis and treatment. We report the cases of invasive ROCM presenting with OAS initially in order to raise the attention of clinicians.

Methods

We retrospectively investigated eleven cases of invasive ROCM presenting initially with OAS admitted between January 2006 and December 2013. We analyzed clinical features, results of laboratory and radiological examinations, nasal endoscopy, aggressive surgical excision and debridement, and medical management outcomes of each case.

Results

A total of eleven cases of invasive ROCM with OAS as an initial sign were presented. Mucormycosis was accompanied by type II diabetes mellitus in nine cases, renal transplant in one case, and injury caused by traffic accident in one case. Anterior rhinoscopy revealed palatine or nasal necrotic lesions in all patients, and transethmoidal optic nerve decompression was carried out in three patients at the same time. CT scan revealed rhino-orbital-cerebral involvement in every patient. All patients were given intravenous amphotericin B. Nine patients underwent surgical debridement of necrotic tissue. Three patients survived.

Conclusions

ROCM is a severe, emergent and fatal infection requiring multidisciplinary management. It may often present with OAS initially. For ophthalmologist, mucormycosis must be considered in immunocompromised patients presenting with OAS initially, and anterior rhinoscopy is imperative before hormonotherapy, even in the cases absent of ketoacidosis induced by diabetes mellitus.
Literature
1.
go back to reference Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis. 1990;12(6):1147–201.CrossRefPubMed Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis. 1990;12(6):1147–201.CrossRefPubMed
2.
go back to reference Hagensee ME, Bauwens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984–1992. Clin Infect Dis. 1994;19(3):402–8.CrossRefPubMed Hagensee ME, Bauwens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984–1992. Clin Infect Dis. 1994;19(3):402–8.CrossRefPubMed
3.
go back to reference Pfaffenbach B, Donhuijsen K, Pahnke J, Bug R, Adamek RJ, Wegener M, et al. Systemic fungal infections in hematologic neoplasms. An autopsy study of 1,053 patients] Med Klin (Munich). 1994;89(6):299–304. Pfaffenbach B, Donhuijsen K, Pahnke J, Bug R, Adamek RJ, Wegener M, et al. Systemic fungal infections in hematologic neoplasms. An autopsy study of 1,053 patients] Med Klin (Munich). 1994;89(6):299–304.
4.
go back to reference Gelston CD, Durairaj VD, Simoes EA. Rhino-orbital mucormycosis causing cavernous sinus and internal carotid thrombosis treated with posaconazole. Arch Ophthalmol. 2007;125(6):848–9.CrossRefPubMed Gelston CD, Durairaj VD, Simoes EA. Rhino-orbital mucormycosis causing cavernous sinus and internal carotid thrombosis treated with posaconazole. Arch Ophthalmol. 2007;125(6):848–9.CrossRefPubMed
5.
go back to reference Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto). Br J Haematol. 1997;99(2):331–6.CrossRefPubMed Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell’Adulto). Br J Haematol. 1997;99(2):331–6.CrossRefPubMed
6.
go back to reference Walsh TJ, Groll AH. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis. 1999;1(4):247–61.CrossRefPubMed Walsh TJ, Groll AH. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis. 1999;1(4):247–61.CrossRefPubMed
8.
go back to reference Van den Saffele JK, Boelaert JR. Zygomycosis in HIV-positive patients: a review of the literature. Mycoses. 1996;39(3–4):77–84.CrossRefPubMed Van den Saffele JK, Boelaert JR. Zygomycosis in HIV-positive patients: a review of the literature. Mycoses. 1996;39(3–4):77–84.CrossRefPubMed
9.
go back to reference Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant. 2006;6(10):2365–74.CrossRefPubMed Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant. 2006;6(10):2365–74.CrossRefPubMed
10.
go back to reference Kauffman CA, Malani AN. Zygomycosis: an emerging fungal infection with new options for management. Curr Infect Dis Rep. 2007;9(6):435–40.CrossRefPubMed Kauffman CA, Malani AN. Zygomycosis: an emerging fungal infection with new options for management. Curr Infect Dis Rep. 2007;9(6):435–40.CrossRefPubMed
11.
go back to reference Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–53.CrossRefPubMed Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–53.CrossRefPubMed
12.
go back to reference Reinhardt DJ, Kaplan W, Ajello L. Experimental cerebral zygomycosis in alloxan-diabetic rabbits I. Relationship of temperature tolerance of selected zygomycetes to pathogenicity. Infect Immun. 1970;2(4):404–13.PubMedPubMedCentral Reinhardt DJ, Kaplan W, Ajello L. Experimental cerebral zygomycosis in alloxan-diabetic rabbits I. Relationship of temperature tolerance of selected zygomycetes to pathogenicity. Infect Immun. 1970;2(4):404–13.PubMedPubMedCentral
13.
go back to reference Sheldon WH, Bauer H. The development of the acute inflammatory response to experimental cutaneous mucormycosis in normal and diabetic rabbits. J Exp Med. 1959;110:845–52.CrossRefPubMedPubMedCentral Sheldon WH, Bauer H. The development of the acute inflammatory response to experimental cutaneous mucormycosis in normal and diabetic rabbits. J Exp Med. 1959;110:845–52.CrossRefPubMedPubMedCentral
14.
go back to reference Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest. 1984;74(1):150–60.CrossRefPubMedPubMedCentral Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest. 1984;74(1):150–60.CrossRefPubMedPubMedCentral
15.
go back to reference Hosseini SM, Borghei P. Rhinocerebral mucormycosis: pathways of spread. Eur Arch Otorhinolaryngol. 2005;262(11):932–8.CrossRefPubMed Hosseini SM, Borghei P. Rhinocerebral mucormycosis: pathways of spread. Eur Arch Otorhinolaryngol. 2005;262(11):932–8.CrossRefPubMed
16.
go back to reference Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10 Suppl 1:31–47.CrossRefPubMed Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10 Suppl 1:31–47.CrossRefPubMed
21.
go back to reference Levin LA, Avery R, Shore JW, Woog JJ, Baker AS. The Spectrum of orbital aspergillosis: A clinicopathological review. Surv Ophthalmol. 1996;41:142–54.CrossRefPubMed Levin LA, Avery R, Shore JW, Woog JJ, Baker AS. The Spectrum of orbital aspergillosis: A clinicopathological review. Surv Ophthalmol. 1996;41:142–54.CrossRefPubMed
22.
go back to reference Kagen SL. Aspergillus: An inhalable contaminant of marihuana. N Engl J Med. 1981;304:483–4.PubMed Kagen SL. Aspergillus: An inhalable contaminant of marihuana. N Engl J Med. 1981;304:483–4.PubMed
23.
go back to reference Stammberger H. Formation of roentgen dense structures in aspergillus mycoses of the paranasal sinuses. HNO. 1985;33:62–4.PubMed Stammberger H. Formation of roentgen dense structures in aspergillus mycoses of the paranasal sinuses. HNO. 1985;33:62–4.PubMed
24.
go back to reference Krennmair G, Lenglinger F, Muller-Schelken H. Computed tomography (CT) in the diagnosis of sinus aspergillosis. J Craniomaxillofac Surg. 1994;22:120–5.CrossRefPubMed Krennmair G, Lenglinger F, Muller-Schelken H. Computed tomography (CT) in the diagnosis of sinus aspergillosis. J Craniomaxillofac Surg. 1994;22:120–5.CrossRefPubMed
25.
go back to reference Talmi YP, Goldschmied-Reouven A, Bakon M, Barshack I, Wolf M, Horowitz Z, et al. Rhino-orbital and rhino-orbito-cerebral mucormycosis. Otolaryngol Head Neck Surg. 2002;127(1):22–31.CrossRefPubMed Talmi YP, Goldschmied-Reouven A, Bakon M, Barshack I, Wolf M, Horowitz Z, et al. Rhino-orbital and rhino-orbito-cerebral mucormycosis. Otolaryngol Head Neck Surg. 2002;127(1):22–31.CrossRefPubMed
26.
go back to reference Toumi A, Larbi Ammari F, Loussaief C, Hadhri R, Ben Brahim H, Harrathi K, et al. Rhino-orbito-cerebral mucormycosis: five cases. Med Mal Infect. 2012;42(12):591–8.CrossRefPubMed Toumi A, Larbi Ammari F, Loussaief C, Hadhri R, Ben Brahim H, Harrathi K, et al. Rhino-orbito-cerebral mucormycosis: five cases. Med Mal Infect. 2012;42(12):591–8.CrossRefPubMed
27.
go back to reference Turunc T, Demiroglu YZ, Aliskan H, Colakoglu S, Arslan H. Eleven cases of mucormycosis with atypical clinical manifestations in diabetic patients. Diabetes Res Clin Pract. 2008;82(2):203–8.CrossRefPubMed Turunc T, Demiroglu YZ, Aliskan H, Colakoglu S, Arslan H. Eleven cases of mucormycosis with atypical clinical manifestations in diabetic patients. Diabetes Res Clin Pract. 2008;82(2):203–8.CrossRefPubMed
28.
go back to reference Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg. 1994;57(4):1044–50.CrossRefPubMed Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg. 1994;57(4):1044–50.CrossRefPubMed
29.
go back to reference Cagatay AA, Oncu SS, Calangu SS, Yildirmak TT, Ozsut HH, Eraksoy HH. Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report. BMC Infect Dis. 2001;1:22.CrossRefPubMedPubMedCentral Cagatay AA, Oncu SS, Calangu SS, Yildirmak TT, Ozsut HH, Eraksoy HH. Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report. BMC Infect Dis. 2001;1:22.CrossRefPubMedPubMedCentral
30.
go back to reference Couch L, Theilen F, Mader JT. Rhinocerebral mucormycosis with cerebral extension successfully treated with adjunctive hyperbaric oxygen therapy. Arch Otolaryngol Head Neck Surg. 1988;114(7):791–4.CrossRefPubMed Couch L, Theilen F, Mader JT. Rhinocerebral mucormycosis with cerebral extension successfully treated with adjunctive hyperbaric oxygen therapy. Arch Otolaryngol Head Neck Surg. 1988;114(7):791–4.CrossRefPubMed
31.
go back to reference Kocak R, Tetiker T, Kocak M, Baslamisli F, Zorludemir S, Gonlusen G. Fluconazole in the treatment of three cases of mucormycosis. Eur J Clin Microbiol Infect Dis. 1995;14(6):559–61.CrossRefPubMed Kocak R, Tetiker T, Kocak M, Baslamisli F, Zorludemir S, Gonlusen G. Fluconazole in the treatment of three cases of mucormycosis. Eur J Clin Microbiol Infect Dis. 1995;14(6):559–61.CrossRefPubMed
Metadata
Title
A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially
Authors
Nan Jiang
Guiqiu Zhao
Shanshan Yang
Jing Lin
Liting Hu
Chengye Che
Qian Wang
Qiang Xu
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2016
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-016-0189-1

Other articles of this Issue 1/2016

BMC Ophthalmology 1/2016 Go to the issue